Large keratoacanthomas treated with intralesional interferon alfa-2a - 12/10/17
Résumé |
Background: Spontaneous involution of giant keratoacanthomas (KAs) can leave large scars or cause mutilation. Human papillomaviruses have recently been demonstrated in KAs. Intralesional interferon alfa-2a (IFN alfa-2a) has been shown to have activity against different epithelial tumors and to have an antiviral effect.
Objective: This study was conducted to determine whether it was possible to stop extension of large KAs, to accelerate healing, and to obtain good cosmetic results with intralesional IFN alfa-2a.
Methods: Six large KAs were treated with intralesional IFN alfa-2a.
Results: Regression was obtained in five cases in 3 to 7 weeks with excellent cosmetic results. The main side effect was pain during injection.
Conclusion: Our results suggest that this treatment hastens healing and limits scarring.
Le texte complet de cet article est disponible en PDF.* | No reprints available. |
Vol 29 - N° 2P1
P. 237-241 - août 1993 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?